Comparative Pharmacology
Head-to-head clinical analysis: CLINIMIX 4 25 25 SULFITE FREE IN DEXTROSE 25 IN PLASTIC CONTAINER versus KABIVEN IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CLINIMIX 4 25 25 SULFITE FREE IN DEXTROSE 25 IN PLASTIC CONTAINER versus KABIVEN IN PLASTIC CONTAINER.
CLINIMIX 4.25/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER vs KABIVEN IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Parenteral nutrition providing amino acids for protein synthesis, dextrose as a carbohydrate calorie source, and electrolytes to maintain physiologic homeostasis.
Kabiven is a parenteral nutrition formulation that provides a balanced mixture of amino acids, dextrose, and lipids to meet nutritional requirements. The amino acids serve as building blocks for protein synthesis, dextrose provides a carbohydrate source for energy, and lipids supply essential fatty acids and additional energy. Electrolytes are included to maintain fluid and electrolyte balance.
Intravenous infusion only. Dosing is individualized based on patient's metabolic needs, weight, and clinical status. Typical adult dose: 1-2 L/day of CLINIMIX 4.25/25, providing 4.25% amino acids and 25% dextrose. Infusion rate should not exceed 3 mg/kg/min for dextrose. Adjust for caloric and nitrogen requirements.
Intravenous infusion. Adult dose based on nutritional needs: typically 0.8-1.5 g amino acids/kg/day, 0.8-1.5 g lipids/kg/day, and 2-4 g dextrose/kg/day. Maximum infusion rate: 1.7 mL/kg/hour (Kabiven Peripher) or 2.6 mL/kg/hour (Kabiven Central).
None Documented
None Documented
Not applicable; components are endogenous substances. Amino acids have rapid clearance (minutes to hours) depending on metabolic demand; dextrose half-life ~1-2 hours in euglycemic state.
Variable; amino acids: 0.5–1 h; lipids: 0.5–1 h (intralipid clearance); glucose: rapid. No true terminal half-life as a mixture.
Amino acids: primarily renal as urea (via ureagenesis) and some as ammonia; dextrose: metabolized to CO2 and water, excreted via lungs and urine. Not applicable as combination product.
Renal: <3% unchanged; primarily metabolized via protein catabolism; nitrogen excretion is renal (urea, ammonia); fat emulsion components are cleared by the reticuloendothelial system and metabolized. Biliary/fecal: negligible.
Category C
Category C
Parenteral Nutrition
Parenteral Nutrition